Customer Logins

Obtain the data you need to make the most informed decisions by accessing our extensive portfolio of information, analytics, and expertise. Sign in to the product or service center of your choice.

Customer Logins

World Markets Pricing and Reimbursement Market Analysis

Optimize your drug pricing, reimbursement and market access strategy

This service tracks pharmaceutical pricing and reimbursement activity across the world. Includes daily analysis, special reports, country profiles, detailed P&R data, as well as our unique international reference pricing matrix and market access risk scores. Via our online platform you can:

  • Understand key price drivers within and across countries
  • Secure market access
  • Anticipate price and reimbursement impact of regulatory changes
  • Compare P&R risks and costs across countries
  • Monitor HTA evaluations of competitor products around the world
  • Understand evolving P&R requirements (comparators, endpoints, clinical trial design)

What’s Included


Global policy and regulatory changes, drug-level P&R events, public health insurance reform, and latest official national spending and pricing trend data

Special Reports (monthly)
Key P&R trends across major pharmaceutical markets

Country Profiles
Continuous updates for 35 countries, covering these topics:

  • Overarching political and economic policy drivers
  • Overview of the pharmaceutical market's P&R structure
  • Regulatory framework, including cost containment analysis
  • Policy change outlook

Reference Pricing Matrix (continuous updates)
Online tool to quickly compare more than 45 countries that use each other for referencing pricing

Risk-sharing Agreement Database (optional)
Track, compare and analyze risk-sharing agreements – both performance and financially-based – around the world

Pricing and Reimbursement Policy Database (continuous updates)
Interactive database of the top 15 cost-containment policies across 35 countries, including:

  • Reference pricing
  • Price cuts
  • Co-payments
  • Pharmaco-economic requirements
  • Generics substitutions

Solve Your Business Challenge

How can I assess the pricing and reimbursement landscape in a new target country?Review Country Profiles to get a clear, detailed view of a country’s pricing, including P&R, funding sources, regulatory and policy outlook.
How can I find out when prices are re-evaluated in reference countries?Use the Reference Pricing Matrix, Country Profiles and Daily Analysis to get real-time pricing reference updates.
I need to identify reference countries and figure out where to launch first.Leverage the Reference Pricing Matrix to easily identify reference and referrer nations and determine optimal route to market.
I struggle to get consistent information across markets.Rely on Country Profiles for consistent cross-country market analysis.
How do I keep pace with P&R changes around the world, and what they mean for me?Get Daily Analysis on likely price shifts due to regulation, and view Country Reports for the latest P&R changes.
I need to re-evaluate my options when processes change in reference countries.Use our P&R Policy Database to compare key players in 35 markets and our Reference Pricing Matrix to find timely referencing country analysis and routes to optimal markets.
I need to understand how to design our clinical trial to secure market access around the world.Use our Daily Analysis to understand evolving requirements, and our Country Reports to understand existing standards.

Industry Success Stories


event image
IHS Markit Event 24 October 2018

Life Sciences Breakfast Briefing

Follow IHS Markit Life Sciences on Twitter


Filter Sort